Cargando…

Severe community-acquired pneumonia: in search of the guiding star

Detalles Bibliográficos
Autores principales:	Póvoa, Pedro, Nseir, Saad, Salluh, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132953/ https://www.ncbi.nlm.nih.gov/pubmed/37100928 http://dx.doi.org/10.1007/s00134-023-07063-2

Ejemplares similares

Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get
por: Salluh, Jorge IF, et al.
Publicado: (2011)

The role of corticosteroids in severe community-acquired pneumonia: a systematic review
por: Salluh, Jorge IF, et al.
Publicado: (2008)

The role of corticosteroids in severe community-acquired pneumonia: a systematic review
por: Salluh, Jorge IF, et al.
Publicado: (2008)

Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey
por: Rabello, Lígia, et al.
Publicado: (2015)

Accuracy of the clinical pulmonary infection score to differentiate ventilator-associated tracheobronchitis from ventilator-associated pneumonia
por: Gaudet, Alexandre, et al.
Publicado: (2020)

Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study
por: Coelho, Luís M, et al.
Publicado: (2012)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey
por: Rodríguez, Alejandro, et al.
Publicado: (2014)

Use of biomarkers in sepsis: many questions, few answers
por: Póvoa, Pedro, et al.
Publicado: (2013)

Ventilator associated tracheobronchitis and pneumonia: one infection with two faces
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Do we need new trials of procalcitonin-guided antibiotic therapy?
por: Lisboa, Thiago, et al.
Publicado: (2018)

Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course
por: Coelho, Luís, et al.
Publicado: (2007)

Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review
por: Póvoa, Pedro, et al.
Publicado: (2012)

Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers
por: Salluh, Jorge IF, et al.
Publicado: (2014)

Corticosteroids for severe community-acquired pneumonia: a story without an ending
por: Rochwerg, Bram
Publicado: (2022)

Ceftaroline in severe community-acquired pneumonia
por: Cilloniz, Catia, et al.
Publicado: (2022)

Impact of Chronic Obstructive Pulmonary Disease on Incidence, Microbiology and Outcome of Ventilator-Associated Lower Respiratory Tract Infections
por: Rouzé, Anahita, et al.
Publicado: (2020)

Severe pneumonia in critically ill cancer patients: clinical outcomes and a comparison between healthcare-associated pneumonia and community-acquired pneumonia
por: Rabello, Ligia SCF, et al.
Publicado: (2013)

Cardiovascular Events after Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies
por: Tralhão, António, et al.
Publicado: (2020)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Community-acquired pneumonia: challenges of the situation in Brazil
por: Gomes, Mauro
Publicado: (2018)

Changes in the epidemiology and burden of community-acquired pneumonia in Korea
por: Yoon, Hyoung Kyu
Publicado: (2014)

Corticosteroids for all adult patients with community-acquired pneumonia?
por: Spoorenberg, Simone M. C., et al.
Publicado: (2015)

Steroids in severe community-acquired pneumonia: dangerous, worthless, or miracle cure? The roller coaster of clinical trials
por: Bouras, Marwan, et al.
Publicado: (2023)

A way towards ventilator-associated lower respiratory tract infection research
por: Martin-Loeches, Ignacio, et al.
Publicado: (2020)

Hyperbaric hyperoxemia as a risk factor for ventilator-acquired pneumonia?
por: Caplan, Morgan, et al.
Publicado: (2021)

Community-acquired pneumonia: The need to broaden our diagnostic armamentarium
por: Perumal, R, et al.
Publicado: (2020)

Corticosteroids for H1N1 associated acute lung injury: is it just wishful thinking?
por: Salluh, Jorge I. F., et al.
Publicado: (2010)

Ventilator-associated tracheobronchitis: an update
por: Salluh, Jorge Ibrain Figueira, et al.
Publicado: (2019)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Factors influencing severity of community-acquired pneumonia
por: Mahendra, M, et al.
Publicado: (2018)

PES Pathogens in Severe Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Noninvasive ventilation routine therapy for community-acquired pneumonia? Not so fast!
por: Hill, N. S.
Publicado: (2001)

Community-acquired pneumonia in Korean children: time to read between the lines
por: Suh, Dong In
Publicado: (2022)

Pneumonia severity index in viral community acquired pneumonia in adults
por: Kim, Mi-Ae, et al.
Publicado: (2019)

C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dog
por: Salluh, Jorge IF, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_m6q83peh1rpul56m6r8mnelqbb